Sickle Cell Care Expansion Act of 2026
The source supplies the latest action, but no lifecycle stage.
Latest action (23 Sep 2026): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
What this bill does
The Sickle Cell Care Expansion Act of 2026, introduced in the Senate, would establish several programs aimed at improving care and research for sickle cell disease. It proposes creating a scholarship and loan repayment program to encourage physicians to focus on sickle cell disease research, treatment, and patient care, especially for adults. The bill also authorizes grants for community-based organizations to develop education and advocacy programs for individuals with sickle cell disease, and for entities to support the transition of pediatric patients with sickle cell disease to adult care.
These programs would primarily affect physicians who choose to specialize in sickle cell disease research or treatment, and individuals and families affected by sickle cell disease who would benefit from enhanced educational outreach and care transition support. Community-based organizations, faith-based organizations, and certain health centers could also be affected by grant opportunities.
The bill was introduced in the Senate on September 23, 2026, and referred to the Committee on Health, Education, Labor, and Pensions. If passed by the Senate, it would then proceed to the House of Representatives for consideration.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
23 Sep 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Common questions
- What does S. 5489 do?
- The Sickle Cell Care Expansion Act of 2026, introduced in the Senate, would establish several programs aimed at improving care and research for sickle cell disease. It proposes creating a scholarship and loan repayment program to encourage physicians to focus on sickle cell disease research, treatment, and patient care, especially for adults. The bill also authorizes grants for community-based organizations to develop education and advocacy programs for individuals with sickle cell disease, and for entities to support the transition of pediatric patients with sickle cell disease to adult care. These programs would primarily affect physicians who choose to specialize in sickle cell disease research or treatment, and individuals and families affected by sickle cell disease who would benefit from enhanced educational outreach and care transition support. Community-based organizations, faith-based organizations, and certain health centers could also be affected by grant opportunities. The bill was introduced in the Senate on September 23, 2026, and referred to the Committee on Health, Education, Labor, and Pensions. If passed by the Senate, it would then proceed to the House of Representatives for consideration.
- Has S. 5489 become law?
- The source does not supply a confirmed lifecycle stage for S. 5489. Check the latest action and official source below.
- Who sponsored S. 5489?
- S. 5489 was sponsored by Sen. Van Hollen, Chris [D-MD] (D-MD), with 2 cosponsors.
- What's the latest action on S. 5489?
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (23 Sep 2026).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
340B Rebate Model Delay Act
Lower Premiums, Faster Payments Act
More bills from Sen. Van Hollen, Chris [D-MD]
Higher Education Grant Flexibility Act of 2026
Ready to Work Act of 2026
No New Fencing At the White House Act
No Fencing at the United States Capitol Complex Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.